0000899243-20-012077.txt : 20200505
0000899243-20-012077.hdr.sgml : 20200505
20200505171658
ACCESSION NUMBER: 0000899243-20-012077
CONFORMED SUBMISSION TYPE: 3
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20200428
FILED AS OF DATE: 20200505
DATE AS OF CHANGE: 20200505
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Gullotta Tina
CENTRAL INDEX KEY: 0001811378
FILING VALUES:
FORM TYPE: 3
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-51531
FILM NUMBER: 20850045
MAIL ADDRESS:
STREET 1: SUNESIS PHARMACEUTICALS,INC
STREET 2: 395 OYSTER POINT BLVD., SUITE 400
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: SUNESIS PHARMACEUTICALS INC
CENTRAL INDEX KEY: 0001061027
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 943295878
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 395 OYSTER POINT BOULEVARD
STREET 2: SUITE 400
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
BUSINESS PHONE: 650-266-3500
MAIL ADDRESS:
STREET 1: 395 OYSTER POINT BOULEVARD
STREET 2: SUITE 400
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
FORMER COMPANY:
FORMER CONFORMED NAME: MOSAIC PHARMACEUTICALS INC
DATE OF NAME CHANGE: 19980709
3
1
doc3.xml
FORM 3 SUBMISSION
X0206
3
2020-04-28
0
0001061027
SUNESIS PHARMACEUTICALS INC
SNSS
0001811378
Gullotta Tina
SUNESIS PHARMACEUTICALS, INC.
395 OYSTER POINT BOULEVARD, SUITE 400
SOUTH SAN FRANCISCO
CA
94080
0
1
0
0
VP, Finance
Common Stock
14500
D
Stock Option (Right to Buy)
2.18
2028-08-31
Common Stock
40000
D
Stock Option (Right to Buy)
0.4157
2028-12-31
Common Stock
8611
D
Stock Option (Right to Buy)
1.215
2029-03-29
Common Stock
10000
D
Stock Option (Right to Buy)
0.4149
2030-03-31
Common Stock
70000
D
One fourth (1/4th) of the shares shall vest one (1) year from the Vesting Commencement Date of August 31, 2018. Thereafter, one forty-eighth (1/48th) of the shares granted shall vest monthly over the next thirty-six (36) months.
One fourth (1/4th) of the shares shall vest one (1) year from the Vesting Commencement Date of December 31, 2018. Thereafter, one forty-eighth (1/48th) of the shares granted shall vest monthly over the next thirty-six (36) months.
One fourth (1/4th) of the shares shall vest one (1) year from the Vesting Commencement Date of March 29, 2019. Thereafter, one forty-eighth (1/48th) of the shares granted shall vest monthly over the next thirty-six (36) months.
One fourth (1/4th) of the shares shall vest one (1) year from the Vesting Commencement Date of March 31, 2020. Thereafter, one forty-eighth (1/48th) of the shares granted shall vest monthly over the next thirty-six (36) months
/s/ Tina Gullotta
2020-05-05